Skip Ribbon Commands
Skip to main content
Forward Look

Be Active About Surveillance

By Heather Stringer

No blanket recommendation exists for active surveillance of men whose prostate cancer has a low risk of progressing.

Guidelines developed by the American Society of Clinical Oncology recommend:
• a PSA test every three to six months;
• a digital rectal exam (DRE) at least every year; and
• a confirmatory biopsy within six to 12 months and follow-up biopsies every two to five years, or more frequently if necessary.

Guidelines developed by the National Comprehensive Cancer Network recommend:
• PSA testing no more often than every six months;
• a DRE no more often than every 12 months; and
• a prostate biopsy no more often than every 
12 months.

Men should speak with their doctors to determine the surveillance schedule that is right for them.

06/24/2016
SUBSCRIBE TO OUR E-NEWSLETTER

Receive monthly updates, including information about web exclusives, events, resources, articles and highlights from new issues—direct to your email inbox. Be among the first to hear the latest news from Cancer Today! Click here to sign up!